Breaking News

‘No such thing as too young to have cancer’: NYU Langone on early-onset trend

09/10/2025

Between 2010 and 2019, incidence rates of 14 cancers increased among individuals younger than 50, with “concerning increases” reported in colorectal and uterine cancer mortality. While the statistics may raise alarm, one oncology expert is encouraging healthcare leaders to understand the full picture. Mary Gemignani, MD, is chief of the…

HHS, FDA to crack down on drug ads

09/10/2025

HHS and the FDA are taking measures to crack down on misleading pharmaceutical advertisements, including digital and broadcast drug ads.  The FDA is sending roughly 100 cease-and-desist letters and thousands of warning letters to drug companies, citing “widespread violations” and deceptive marketing practices, according to a Sept. 9 news release…

HHS commission releases strategy for children’s health: 5 takeaways

09/09/2025

The Make America Healthy Again Commission, a newly created advisory body under HHS, published a report on chronic disease and children’s health Sept. 9.  The commission’s “Make Our Children Healthy Again Strategy” covers a slew of topics, including environmental chemicals, ultra-processed foods, screen time and “overmedicalization,” which the report describes…

Novartis to expand cardiovascular drug portfolio with $1.4B deal

09/09/2025

Novartis is acquiring biopharmaceutical company Tourmaline Bio for $1.4 billion to boost its cardiovascular pipeline.  Tourmaline develops pacibekitug, a drug used to treat atherosclerotic cardiovascular disease, according to a Sept. 9 news release from Novartis.  Novartis said the drug is in advanced phase 2 clinical trials and works to combat…

Infusion efficiency overhaul delivers $6M in annual ROI for Baptist MD Anderson

09/09/2025

Infusion volumes at Baptist MD Anderson Cancer Center in Jacksonville, Fla., have more than doubled since 2019, surpassing 39,000 annual visits, without adding a single chair. This growth, which includes a 140% increase in daily scheduled volumes and a 13% boost in chair efficiency, was achieved through data-driven redesign, predictive…

Reimagining Cancer Screening: How Multi-Cancer Early Detection Is Reshaping Care for Aggressive Cancers

09/09/2025

Imagine a future where some cancers are caught before symptoms appear, before they spread, before lives are disrupted. That’s the potential of multi-cancer early detection (MCED), a transformative approach that’s reshaping how healthcare leaders think about cancer screening. In 2025 alone, over 2 million new cancer cases and more than 618,000…

Cut Energy Costs Without Cutting into Patient Investment

09/09/2025

Rethinking the Capital Equation in Hospital Finance Hospital CFOs are under increasing pressure to balance competing financial demands. Rising utility costs, deferred maintenance, and aging infrastructure strain operating budgets, while investments in staffing, technology, and patient care require every available dollar. Too often, this creates a financial stalemate: delaying upgrades…

Top-paid specialties for nurse practitioners, physician assistants

09/09/2025

Compensation for physician assistants and nurse practitioners varies across specialties, according to a survey conducted by consulting firm SullivanCotter The “2025 Advanced Practice Provider Compensation and Productivity Survey” draws data from more than 785 health systems, hospitals and physician group practices representing more than 155,000 certified anesthesiologist assistants, certified nurse…

Disaster preparedness in 2025: Recommendations for healthcare chief executive officers

09/09/2025

September is National Preparedness Month, which aims to raise awareness about the importance of preparing for emergencies. The American College of Healthcare Executives advises healthcare executives to actively participate in disaster preparedness for natural and man-made disasters. This advice has never been more relevant as healthcare organizations plan for the…

Hospital group urges federal probe of drugmakers’ 340B rebate models: 5 notes

09/08/2025

The American Hospital Association is calling on federal regulators to launch an antitrust investigation into its claims of drug manufacturers’ actions regarding 340B rebate models.  In a letter sent to the Federal Trade Commission and the Department of Justice, the AHA accused several pharmaceutical giants of undermining the 340B drug…